Oncology
2 drugs are in development for Minimal Residual Disease.
- Companies
- 1
- Clinical trials
- 8
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Minimal Residual Disease pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| eli-002 | Elicio Therapeutics, Inc. (ELTX) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| eli-002 2p | Elicio Therapeutics, Inc. (ELTX) |
About this indication
Minimal Residual Disease context
Oncology·MeSH: Neoplasm, Residual (D018365)
Also known as: Minimal Residual Diseases, Residual Minimal Disease, Residual Minimal Diseases, Residual Neoplasm, Residual Neoplasms
Frequently asked questions
How many drugs are in development for Minimal Residual Disease?
BioSniper tracks 2 drugs in development for Minimal Residual Disease across 1 company.
How many clinical trials target Minimal Residual Disease?
There are 8 clinical trials targeting Minimal Residual Disease tracked by BioSniper.